Funded Startups in Oxford
Among the 50 most recent disclosed rounds shown, the largest disclosed amount is $142M for OrganOx (2025-02-24), which dwarfs the next-largest disclosed fi…
Among the 50 most recent disclosed rounds shown, the largest disclosed amount is $142M for OrganOx (2025-02-24), which dwarfs the next-largest disclosed figures such as Grey Wolf Therapeutics at $50M (2024-05-23) and Genomics at $45M (2024-01-08). Smaller deals cluster heavily in the $2M–$10M range, with several $6M rounds (e.g., Caudal Energy at $6M on 2026-05-27; Diffblue at $6M on 2024-10-30; Machine Discovery at $6M on 2023-09-26), while the smallest disclosed amount is $10K for Apothecary & Co (2023-08-23).
Geographically, 48 of 50 rows are in Oxford, Oxfordshire, United Kingdom, with one clear exception outside the city/state label—Apothecary & Co in Oxford, Michigan (2023-08-23). Temporally, the listed rounds span from 2023-06-27 (Charisma, undisclosed) to 2026-06-25 (Covatic, $2M), and there is a dense wave of Oxford rounds across mid-2024 (e.g., PQShield $37M on 2024-06-20; Reactive Technologies $32M on 2024-05-21; Pathios Therapeutics $25M on 2024-04-18). Stage labeling is frequently non-specific: 12 of 50 rows are marked either “Series Unknown” or “Venture - Series Unknown” or have an empty/blank stage field.
Most recent rounds
50 of 9141 more funded startups
This page shows the 50 most recent rounds (back to Jun 2023). The full 91-company history for this listing is available on a paid plan.
Unlock all 91 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the biggest disclosed round in the Oxford list, and how does it compare to other large deals?
OrganOx’s $142M round (2025-02-24) is the standout outlier versus the next-largest disclosed amounts, including Grey Wolf Therapeutics at $50M (2024-05-23) and Genomics at $45M (2024-01-08). Several other sizeable Oxford rounds sit well below that level, such as PQShield $37M (2024-06-20) and Reactive Technologies $32M (2024-05-21).
Are there any clear city/geography exceptions compared with the rest of the Oxford entries?
The list is overwhelmingly Oxford, Oxfordshire, United Kingdom (48 of 50 rows). The main exception is Apothecary & Co in Oxford, Michigan (2023-08-23) with only $10K, which also makes it the smallest disclosed amount on the page.
Do the rounds concentrate in a particular time window rather than spreading evenly across years?
Yes—there’s a noticeable density through mid-2024, where multiple large disclosed rounds appear: Grey Wolf Therapeutics $50M (2024-05-23), Reactive Technologies $32M (2024-05-21), Pathios Therapeutics $25M (2024-04-18), and PQShield $37M (2024-06-20). In contrast, the newest entries cluster at the end of the range, with the most recent round on 2026-06-25 (Covatic, $2M).
Which stage classifications dominate, and how often is the stage unclear?
Non-specific stage labeling is common: 12 of 50 rows are “Series Unknown,” “Venture - Series Unknown,” or have a blank stage field (e.g., Low Carbon Hub on 2026-05-20 at $760K; Salience Labs on 2025-10-03 with undisclosed; Stayf on 2024-03-26 with $710K and a blank stage). By comparison, clearly labeled stages like Seed, Series A/B/C/D appear repeatedly but not as consistently as the “Unknown/blank” labels.
Are there repeated deal sizes that suggest a narrow funding band within the Oxford cohort?
Several disclosed rounds recur around $6M: Caudal Energy ($6M on 2026-05-27), Diffblue ($6M on 2024-10-30), and Machine Discovery ($6M on 2023-09-26). This sits alongside many other mid-range disclosed amounts (e.g., Scripta Therapeutics $12M on 2025-11-13; Oxford Endovascular $10M on 2024-05-20), indicating fewer entries at the extremes except for OrganOx’s $142M outlier.
Which sectors appear frequently enough to form a cluster in this dataset?
Biotechnology shows up across many rows (e.g., Entelo Bio $4M on 2026-04-24; Theolytics $9M on 2026-03-04; Wild Bioscience $60M on 2025-10-16; OXCCU $28M on 2025-10-04), making it the most prominent multi-entry theme. Healthcare also clusters repeatedly (e.g., OrganOx; Oxford Endovascular; Perspectum at $250K on 2024-11-14), while other sectors tend to appear less often.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.